Results 1 to 10 of about 4,471 (177)

Ocular reaction to timolol maleate [PDF]

open access: yesPostgraduate Medical Journal, 1979
A patient prescribed timolol maleate for the control of hypertension developed dryness of the eyes. The symptoms improved on withdrawal of the drug. Vigilance for such adverse reactions must be observed in the use of any beta-adrenoreceptor blocking agent.
M A, Frais, T J, Bayley
openaire   +2 more sources

Cardiovascular effects of timolol maleate, brimonidine or brimonidine/timolol maleate in concomitant therapy [PDF]

open access: yesActa Ophthalmologica Scandinavica, 2002
ABSTRACT.Purpose:  To examine the influence on maximal exercise performance in young healthy volunteers of timolol 0.5%, brimonidine 0.2% or placebo versus brimonidine 0.2% and timolol 0.5% used concomitantly.Methods:  The subjects in this prospective, double‐masked, crossover comparison were dosed 15 min prior to treadmill testing.
William C, Stewart   +2 more
openaire   +2 more sources

Pharmacogenetics of ophthalmic topical β-blockers [PDF]

open access: yes, 2008
Glaucoma is the second leading cause of blindness worldwide. The primary glaucoma risk factor is elevated intraocular pressure. Topical β-blockers are affordable and widely used to lower intraocular pressure.
McCarty, Catherine A.   +4 more
core   +1 more source

Enhancement and inhibition effects on the corneal permeability of timolol maleate: polymers, cyclodextrins and chelating agents [PDF]

open access: yes, 2017
This study investigates how both bioadhesive polymers (chitosan, hyaluronic acid and alginate) and permeability enhancers (ethylene glycol- bis(2-aminoethylether)- N, N, N', N'- tetraacetic acid (EGTA) and hydroxypropyl-ß-cyclodextrin) influence the ...
Khutoryanskiy, Vitaliy V.   +3 more
core   +1 more source

Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells [PDF]

open access: yes, 2010
Masahiko Ayaki1, Atsuo Iwasawa2, Yoichi Inoue31Department of Ophthalmology, Saitama National Hospital, Wako, Japan; 2Life Particle Interaction Engineering Creation, New Industry Creation Hatchery Center, Tohoku University, Sendai, Japan; 3Department of ...
Masahiko Ayaki   +2 more
core   +2 more sources

The parallel lives of polysaccharides in food and pharmaceutical formulations [PDF]

open access: yes, 2015
The present opinion article discusses how polysaccharide structures can be used in both food and pharmaceutical formulations. We distinguish two regions depending on moisture content where polysaccharides form structures with distinct functional ...
Kontogiorgos, Vassilis   +2 more
core   +1 more source

Electrically atomised formulations of timolol maleate for direct and on-demand ocular lens coatings [PDF]

open access: yes, 2017
The file attached to this record is the author's final peer reviewed version.
Ahmad, Zeeshan   +6 more
core   +2 more sources

24-h Efficacy of Glaucoma Treatment Options [PDF]

open access: yes, 2016
Current management of glaucoma entails the medical, laser, or surgical reduction of intraocular pressure (IOP) to a predetermined level of target IOP, which is commensurate with either stability or delayed progression of visual loss.
Banu, Bozkurt.   +8 more
core   +2 more sources

Effect of prophylactic timolol 0.1% gel on intraocular pressure after an intravitreal injection of ranibizumab: a randomized study [PDF]

open access: yes, 2016
Purpose: The purpose of this study is to make a prospective evaluation of the effect of timolol 0.1% eye gel on short-term intraocular pressure (IOP) after an intravitreal injection (IVI) of ranibizumab. Participants and methods: One hundred and fifty
Allegrini, D.   +3 more
core   +7 more sources

Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial [PDF]

open access: yes, 2013
OBJECTIVES: To compare ocular surface changes induced via glaucoma treatment in patients using fixed combinations of prostaglandin analogues (travoprost, latanoprost and bimatoprost) with 0.5% timolol maleate METHODS: A prospective, multicenter ...
Barros, Jeison de Nadai   +6 more
core   +3 more sources

Home - About - Disclaimer - Privacy